Loss of HMG-CoA reductase in C. elegans causes defects in protein prenylation and muscle mitochondria.
HMG-CoA reductase is the rate-limiting enzyme in the mevalonate pathway and the target of cholesterol-lowering statins. We characterized the C. elegans hmgr-1(tm4368) mutant, which lacks HMG-CoA reductase, and show that its phenotypes recapitulate that of statin treatment, though in a more severe fo...
Main Authors: | Parmida Ranji, Manish Rauthan, Christophe Pitot, Marc Pilon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4053411?pdf=render |
Similar Items
-
Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase
by: Stanley Goldfarb, et al.
Published: (1972-11-01) -
HMG-CoA reductase is not the site of the primary defect in phytosterolemia
by: G.M.B. Berger, et al.
Published: (1998-05-01) -
Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01) -
Activation of HMG-CoA reductase by microsomal phosphatase
by: K R Feingold, et al.
Published: (1983-03-01) -
Regulation of HMG-CoA reductase activity in plants.
by: B A Stermer, et al.
Published: (1994-07-01)